Clinical Trial Update: Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating intravenous infusion of umbilical cord mesenchymal stem cells for aging frailty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging Frailty

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells Infusion (umbilical cord-derived mesenchymal stem cells infusion)

Snippet

Sponsor: Shanghai East Hospital | Conditions: Aging Frailty | Phase 1, Phase 2 | Status: COMPLETED